Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Americord Announces Appointment of Andrew Horne

Americord
Posted on: 21 Oct 16

Americord, the fastest growing cord blood bank in the country, and a leader in the advancement of umbilical cord blood, cord tissue, and placenta tissue banking has announced that Andrew Horne has joined the company as in-house interim General Counsel.

Mr. Horne brings over 15 years of relevant experience to Americord, having represented companies in an array of fields including technology, pharmaceutical, biotech, insurance, telecommunications, defense and entertainment. Prior to joining Americord, he was a litigation partner at Kirkland & Ellis LLP and taught international private law and tort law at the University of Strathclyde in Glasgow, Scotland.

“As Americord continues to grow in the evolving field of stem cell science and cord blood banking, we are pleased to have Andrew on the management team.” says Martin Smithmyer, CEO and founder. “His experience in the biotech sphere will help us navigate the regulatory environment both in terms of operations and patient advocacy. ”

Mr. Horne is a current member of the Americord Registry Advisory Board. He holds degrees from Harvard Law School (LL.M.), Glasgow Graduate School of Law (Dip. L.P.) and University of Strathclyde (LL.B.). He is a former Associate Fellow at the Society for Advanced Legal Studies and was a John F. Kennedy Memorial Scholar at Harvard Law School.

About Americord Registry (“Americord”)

Americord Registry is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company’s laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. For more information, visit www.americordblood.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161021005012/en/

Business Wire
www.businesswire.com

Last updated on: 21/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.